PMID,Title,Journal,Year
39322597,Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review.,BMJ open,2024
39248270,Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial.,Journal of the American Heart Association,2024
38325352,Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass.,Cardiorenal medicine,2024
36207048,Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol.,BMJ open,2022
33394226,An update on vascular calcification and potential therapeutics.,Molecular biology reports,2021
32897516,Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study.,Endocrine,2021
31897759,No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis.,Archives of osteoporosis,2020
30690785,"Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial.",Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,2019
23456027,Vascular calcification: an update on mechanisms and challenges in treatment.,Calcified tissue international,2013
